Specialized Glial Subtypes in Neuroimmune Crosstalk and Disease Progression

A special issue of Neuroglia (ISSN 2571-6980).

Deadline for manuscript submissions: 30 August 2026 | Viewed by 1203

Editor


E-Mail Website
Guest Editor
Department of Life Sciences and Health, Faculty of Health Sciences, Oslo Metropolitan University, 0130 Oslo, Norway
Interests: neuroscience; neurology; pain; headache; migraine; neuropharmacology; neurons; glia; brain organoids

Special Issue Information

Dear Colleagues,

Glial cells have emerged as central orchestrators of neuroimmune communication, extending far beyond their classical supportive roles to actively shape neural function, systemic homeostasis, and disease trajectories. Advances in single-cell profiling, imaging, and functional genomics have revealed an unexpected diversity of specialized glial subtypes, including disease-associated microglia, context-dependent astrocyte phenotypes, NG2-glia, oligodendrocyte lineage cells, and peripheral glial populations, each contributing in distinct ways to inflammation, metabolism, synaptic plasticity, and tissue repair.

This Special Issue aims to bridge fundamental glial biology with translational and therapeutic innovation, highlighting how insights into glial heterogeneity can reshape our understanding of disease mechanisms and open new avenues for intervention. We welcome contributions that span molecular discovery, experimental models, biomarker development, and early-phase clinical translation, with particular interest in work that explores glial–immune interfaces in chronic pain, neurodegeneration, neuropsychiatric disorders, fatigue syndromes, metabolic and autoimmune diseases, and brain–body communication.

By integrating basic mechanistic science with applied and clinical perspectives, this collection seeks to accelerate the development of glia-targeted diagnostics and therapeutics—from precision pharmacology and immunomodulation to digital biomarkers and personalized care strategies—positioning specialized glia at the forefront of next-generation neuroimmune medicine.

Prof. Dr. Parisa Gazerani
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Neuroglia is an international peer-reviewed open access quarterly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • specialized glial subtypes
  • neuroimmune crosstalk
  • glial heterogeneity and plasticity
  • disease-associated microglia (DAM)
  • reactive astrocyte phenotypes
  • NG2-glia and oligodendrocyte lineage
  • peripheral glia and satellite glial cells
  • neuroinflammation and immune modulation
  • glia-targeted therapeutics
  • translational neuroscience
  • precision medicine in neuroimmune disorders
  • chronic pain, fatigue, and neuroimmune mechanisms
  • biomarkers and digital phenotyping in glial research

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

31 pages, 1018 KB  
Review
The Role of Satellite Glial Cells in Opioid Modulation and Chronic Pain: A Systematic Review
by Lionete Gall Acosta Filha, Carolina Kaminski Sanz, Elisa Vieira Rocha, Yasmim Almeida Nunes, Felipe Silva dos Santos, Parisa Gazerani and Marcos Fabio Henriques dos Santos
Neuroglia 2026, 7(3), 26; https://doi.org/10.3390/neuroglia7030026 - 27 Jul 2026
Viewed by 455
Abstract
Satellite glial cells (SGCs) play a critical role in the development and maintenance of chronic pain through complex interactions with inflammatory mediators and the opioid pathway. This systematic review synthesizes recent advances in the molecular mechanisms underlying SGC activation and implications for chronic [...] Read more.
Satellite glial cells (SGCs) play a critical role in the development and maintenance of chronic pain through complex interactions with inflammatory mediators and the opioid pathway. This systematic review synthesizes recent advances in the molecular mechanisms underlying SGC activation and implications for chronic pain management, particularly in conditions associated with the dorsal root ganglia (DRG) and trigeminal ganglia (TG). A systematic search was conducted in four databases (PubMed, Embase, Scopus, and Web of Science) covering studies published between January 2004 and May 2026. After screening 111 records, 19 studies were included. This review highlights how pro-inflammatory cytokines such as IL-1β, IL-1α, and TNF-α, as well as neurotransmitters like ATP and glutamate, contribute to SGC activation, neuroinflammation, and pain modulation. It also explores the role of receptors like CXCR4, TLR4, and P2X7 in SGCs in enhancing analgesic effects and their contributions to opioid tolerance and hyperalgesia. The findings underscore the potential of targeting SGCs to improve pain management outcomes across various pain models, including neuropathic, cancer-related, and visceral pain. Despite promising insights, variability in study methodologies and the complexity of glial–neuronal interactions present challenges. Future research should focus on standardizing experimental protocols and developing targeted therapies to modulate SGC activity to offer hope for patients suffering from chronic pain, particularly in managing opioid tolerance. Full article
Show Figures

Figure 1

Back to TopTop